Depomed to Report Fourth Quarter Fiscal Year 2017 Financial Results on Tuesday, February 27, 2018
February 20 2018 - 4:05PM
Depomed, Inc. (NASDAQ:DEPO) today announced that it will release
fourth quarter fiscal year 2017 financial results on Tuesday,
February 27, 2018, after the close of markets. The Company will
host a conference call beginning at 4:30 p.m. EST (1:30 p.m. PST)
to discuss its results.
Participants can access the live webcast from the Investor
Relations section of Depomed's website at http://www.depomed.com.
Please access the website 15 minutes prior to the start of the call
to download and install any necessary audio software. An archived
webcast replay will be available on the Company's website for three
months.
Audio Conference Call:
U.S. Dial-in
Number: |
1-844-839-0046 |
International Dial-in
Number: |
1-857-270-6032 |
Conference ID: |
2157887 |
An archived webcast replay will be available on the Company's
website for three months.
About Depomed
Depomed is a leading specialty pharmaceutical company committed
to putting the Patient First in everything it does. Depomed is
focused on enhancing the lives of patients, families, physicians,
providers and payors through the commercialization of products in
the areas of pain and neurology, and in the development of drugs in
areas of unmet medical need. Depomed currently markets three
medicines focused on neuropathic pain and migraine through its
Neurology and Pain businesses and its emerging Specialty Business
is focused on orphan drug indications and areas of unmet medical
need. To learn more about Depomed, visit www.depomed.com.
INVESTOR AND MEDIA CONTACTS:
Christopher Keenan VP, Investor Relations and Corporate
Communications 510-744-8000 ckeenan@depomed.com
Daniel Peisert VP, Business Development dpeisert@depomed.com
Depomed, Inc. (delisted) (NASDAQ:DEPO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Depomed, Inc. (delisted) (NASDAQ:DEPO)
Historical Stock Chart
From Sep 2023 to Sep 2024